New Human Data Suggests Psychedelics May Reduce Inflammation in Neurodegenerative Diseases

Recent human data supports previous lab findings that psychedelics such as psilocybin can reduce inflammation. This emerging evidence highlights the potential of these substances to benefit patients with neurodegenerative diseases like Parkinson's disease. The findings mark an important step toward understanding psychedelics' therapeutic effects beyond mental health.

Originally published by npr